Oncogene pathway activation in mammary tumors dictates FDG-PET uptake.
Alvarez JV, Belka GK, Pan TC, Chen CC, Blankemeyer E, Alavi A, Karp JS, Chodosh LA.
Cancer Res. 2014. 74:7583-98.
SPSB1 promotes breast cancer recurrence by potentiating c-MET signaling.
Feng Y, Pan TC, Pant DK, Chakrabarti KR, Alvarez JV, Ruth JR, Chodosh LA.
Cancer Discov. 2014. 4:790-803.
Par-4 downregulation promotes breast cancer recurrence by preventing multinucleation following targeted therapy.
Alvarez JV, Pan TC, Ruth J, Feng Y, Zhou A, Pant D, Grimley JS, Wandless TJ, Demichele A, I-SPY 1 TRIAL Investigators, Chodosh LA.
Cancer Cell. 2013. 24:30-44.
Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor.
Alvarez JV, Greulich H, Sellers WR, Meyerson M, Frank DA.
Cancer Res. 2006. 66:3162-8.
Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors.
Alvarez JV, Febbo PG, Ramaswamy S, Loda M, Richardson A, Frank DA.
Cancer Res. 2005. 65:5054-62.